A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
Clinical trial NCT06268873 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06268873
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-29
- Primary completion
- 2028-02-24
- Enrollment
- 2554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.